HOLLAND & KNIGHT LLP

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $50,000.00 income · posted Oct 20, 2025

Bills named in this filing 1

Lobbying activity 2

Budget/Appropriations

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

Health Issues

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.